Cite Filings / TARS
Feed Companies Filings Check
Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
Filings Financials Insiders Search text
All 677 Financials 97 Shareholder Meetings 6 Executive Compensation 84 Insider Trading 330 Beneficial Ownership Interest 69 Business Combinations 72 Public Offerings 28 Mutual Funds and ETFs 6 Others 153
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2020-10-09
  3. S-1/A Offering Registration Statement 2020-10-09
  4. UPLOAD Other SEC-generated Letter 2020-10-07
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2020-10-06
  6. CORRESP Other Correspondence Between Filers and SEC Staff 2020-09-25
  7. S-1 Offering Registration Statement 2020-09-25
  8. UPLOAD Other SEC-generated Letter 2020-09-24
  9. UPLOAD Other SEC-generated Letter 2020-09-04

Page 2 of 2 · 28 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…